Back
Madrigal Pharmaceuticals Vs. ADMA Biologics Industry Stock Comparison
Sell
50
MDGL
Madrigal Pharmaceuticals
Last Price:
289.45
Seasonality Move:
35.27%
Buy
66
ADMA
ADMA Biologics
Last Price:
19.04
Seasonality Move:
3.76%
Sell
50
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $288.58. The Score for MDGL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
ADMA Biologics (ADMA)
is a Buy
Is ADMA Biologics a Buy, Sell or Hold?
- The current ADMA Biologics [ADMA] share price is $19.04. The Score for ADMA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- ADMA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $288.58
The current trend is moderately bearish and MDGL is experiencing slight buying pressure.
ADMA Stock Price Chart
What is ADMA Biologics's stock price today?
-
The ADMA Biologics share price today is $19.04
The current trend is moderately bearish and ADMA is experiencing selling pressure, which indicates risk of future bearish movement.
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 25.46 | Buy |
| Relative Strength Index (14 RSI): | 53.61 | Buy |
| Chaikin Money Flow: | 35135 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (206.64 - 323.96) | Buy |
| Bollinger Bands (100): | (218.15 - 292.53) | Buy |
ADMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.85 | Buy |
| Relative Strength Index (14 RSI): | 50.3 | Buy |
| Chaikin Money Flow: | -3507011 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.79 - 20.35) | Buy |
| Bollinger Bands (100): | (13.24 - 19.5) | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 328.65 | Sell |
| 20-day SMA: | 277.82 | Buy |
| 50-day SMA: | 244.53 | Buy |
| 200-day SMA: | 246.32 | Buy |
| 8-day EMA: | 312.02 | Sell |
| 20-day EMA: | 289.6 | Sell |
| 50-day EMA: | 262.38 | Buy |
| 200-day EMA: | 243.52 | Buy |
ADMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.88 | Sell |
| 20-day SMA: | 18.47 | Buy |
| 50-day SMA: | 18.55 | Buy |
| 200-day SMA: | 11.81 | Buy |
| 8-day EMA: | 20.26 | Sell |
| 20-day EMA: | 19.34 | Sell |
| 50-day EMA: | 18.2 | Buy |
| 200-day EMA: | 13.11 | Buy |
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $4.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.14 per share, and an increase next year of $9.75 per share.
ADMA Biologics Earnings Growth & ADMA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.22 per share.
Madrigal Pharmaceuticals Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ADMA Biologics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||